SMS Pharmaceuticals Limited has filed a regulatory disclosure regarding the rescheduling of its Board of Directors meeting. The company had previously intimated on 25th July, 2026 that a board meeting was scheduled for Saturday, 1st August, 2026 to consider and approve the unaudited (Standalone and Consolidated) Financial Results for the first quarter ended 30th June, 2026.
Due to unavoidable administrative exigencies, the meeting has been preponed and will now be held on Friday, 31st July 2026. The agenda remains unchanged - the board will transact the same business as previously intimated, specifically considering and approving the Q1 FY2027 financial results.
The company confirms that its trading window for equity shares remains closed from 1st July, 2026 to 2nd August, 2026 (both days inclusive) as previously communicated to designated persons including directors. The trading window will reopen on 3rd August, 2026. This closure is in accordance with the Company's Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations, 2015.
The disclosure is made under Regulation 29 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The communication is signed by Thirumalesh Tumma, Company Secretary & Compliance Officer, and was digitally signed on 29th July, 2026 at 12:15:02 IST.